Rockefeller Capital Management
LXRX icon

Rockefeller Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Rockefeller Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$523 Hold
335
– – ﹤0.01% 4557
2025
Q4 		$385 Hold
335
– – ﹤0.01% 4551
2025
Q3 		$452 Buy
+335
New +$380 ﹤0.01% 4280
2023
Q1 		– Sell
-3,000
Closed -$5K – 3090
2022
Q4 		$5K Buy
+3,000
New +$6.38K ﹤0.01% 3331
2021
Q1 		– Sell
-182
Closed – – 3335
2020
Q4 		$0 Buy
+182
New +$347 ﹤0.01% 2948

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Rockefeller Capital Management's LXRX Position: Q1 2026 in Review

Rockefeller Capital Management held its Lexicon Pharmaceuticals (LXRX) position steady in Q1 2026 at 335 shares worth $523. The position accounts for ﹤0.01% of the portfolio, ranked #4557.

Rockefeller Capital Management first reported a position in LXRX in Q4 2020 and has held it in 5 quarters since. The position peaked at $5K in Q4 2022. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Rockefeller Capital Management held 335 shares of Lexicon Pharmaceuticals worth $523 as of Q1 2026.
  • Rockefeller Capital Management left its Lexicon Pharmaceuticals share count unchanged in Q1 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4557 holding.
  • Rockefeller Capital Management first reported a position in Lexicon Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Lexicon Pharmaceuticals position peaked at $5K in Q4 2022.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.